[1]
“A CLINICAL REVIEW ON CHRONIC OBSTRUCTIVE PULMONARY DISEASES AFTER COVID 19 PANDEMIC ”, Int. Res. J. Pharm., vol. 17, no. 6, pp. 18–24, Jun. 2026, doi: 10.56802/rtqh6984.